Drug Approval | April 17, 2026
Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
The company reported net revenue of SEK 13.5 million for the full year 2025
Former Wavemaker executive to lead media strategy and digital transformation agenda
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
Subscribe To Our Newsletter & Stay Updated
